Skip to main content

The effect of direct application of dexamethasone on the round window membrane in patients with sudden sensorineural hearing loss



The aim of this study was to test the effect of direct application of dexamethasone on the round window (RW) after its adequate exposure following a transcanal approach in patients with sudden sensorineural hearing loss (SSNHL).

Study design

This investigation was designed to be a prospective cohort study.

Patients and methods

This study included eighteen adult patients with SSNHL who attended our outpatient clinic at Alexandria Main University Hospital between 1 July 2015 and 1 July 2016. Under general anesthesia the small tympanomeatal flap was elevated to visualize the RW. If it was fully exposed, dexamethasone (4 mg/ml) was applied directly over a piece of gel foam; if not fully exposed the overhang was removed first and then dexamethasone was applied. After 2 weeks, a repeat audiogram was taken in all patients in order to evaluate the efficacy of the treatment on their hearing ability.


Post-treatment assessment revealed 50% of patients with variable levels of improvement, whereas 50% did not respond to the given treatment. Of the patients showing improvement, 16.7% had normal hearing levels restored. Thus, direct application of dexamethasone on the RW membrane after its adequate exposure may reverse the hearing deficits in a few patients with SSNHL.


There is a definitive improvement in hearing in patients with SSNHL on direct application of dexamethasone on the RW membrane after its adequate exposure in patients.


  1. 1

    Na SY, Kim MG, Hong SM, Chung JH, Kang HM, Yeo SG. Comparison of sudden deafness in adults and children. Clin Exp Otorhinolaryngol 2014; 7:165–169.

    Article  Google Scholar 

  2. 2

    Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 2010; 120:1011–1021.

    Article  Google Scholar 

  3. 3

    Lee SH, Choi SK, Lim YJ. Otologic manifestations of acoustic neuroma. Acta Otolaryngol 2015; 135:140–146.

    Article  Google Scholar 

  4. 4

    Stachler RJ, Chandrasekhar SS, Archer SM. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012; 146(3 Suppl):S1–S35.

    Article  Google Scholar 

  5. 5

    Kim YH, Park KT, Choi BY. Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance. Eur Arch Otorhinolaryngol 2012; 269:2173–2178.

    Article  Google Scholar 

  6. 6

    Fu Y, Zhao H, Zhang T, Chi F. Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: clinical evaluation and laboratory investigation. Auris Nasus Larynx. 2011; 38:165–171.

    Article  Google Scholar 

  7. 7

    Alexander TH, Harris JP. Incidence of sudden sensorineural hearing loss. Otol Neurotol 2013; 34:1586–1589.

    Article  Google Scholar 

  8. 8

    Rarey KE, Luttge WG. Presence of type I and type II/IB receptors for adrenocorticosteroid hormones in the inner ear. Hear Res 1989; 41:217–221.

    CAS  Article  Google Scholar 

  9. 9

    Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006; 27:564–569.

    PubMed  Google Scholar 

  10. 10

    Sun JJ, Liu Y, Kong WJ. In vitro permeability of round window membrane to transforming dexamethasone with delivery vehicles – dosage estimation. Chin Med J (Engl) 2007; 120:2284–2289.

    CAS  Article  Google Scholar 

  11. 11

    Harris JP. Inner ear medicine: targeted therapy. Editorial. Audiol Neurootol 2009; 14:349.

    Article  Google Scholar 

  12. 12

    Goycoolea MV. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol 2001; 121:437–447.

    CAS  Article  Google Scholar 

  13. 13

    Byl FM Jr Sudden hearing loss: eight years’ experience and suggested prognostic table. Laryngoscope 1984; 94:647–661.

  14. 14

    Wu CS, Lin HC, Chao PZ. Sudden sensorineural hearing loss: evidence from Taiwan. Audiol Neurootol 2006; 11:151–156.

    Article  Google Scholar 

  15. 15

    Bogaz EA, Maranhao ASA, Inoue DP, Suzuki FAB, Penido NO. Variables with prognostic value in the onset of idiopathic sudden sensorineural hearing loss. Braz J Otorhinolaryngol 2015; 81:520–526.

    Article  Google Scholar 

  16. 16

    Ben-David J, Luntz M, Podoshin L. Vertigo as a prognostic sign in sudden sensorineural hearing loss. Int Tinnitus J 2002; 8:127–128.

    PubMed  Google Scholar 

  17. 17

    Marcucci R, Alessandrello Liotta A, Cellai AP. Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss. J Thromb Haemost 2005; 3:929–934.

    CAS  Article  Google Scholar 

  18. 18

    Ullrich D, Aurbach G, Drobik C. A prospective study of hyperlipidemia as a pathogenic factor in sudden sensorineural hearing loss. Eur Arch Otolarhinolaryngol 1992; 249:273–276.

    CAS  Article  Google Scholar 

  19. 19

    Chang NC, Ho KY, Kuo WR. Audiometric patterns and prognosis in sudden sensorineural hearing loss in Southern Taiwan. Otolaryngol Head Neck Surg 2005; 133:916–922.

    Article  Google Scholar 

  20. 20

    Silverstien H, Choo D, Rosenberg SI, Kuhun J, Seidman M, Stein I. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996; 75:468–471.

    Article  Google Scholar 

  21. 21

    Loader B, Atteneder C, Kaider A, et al. Tympanotomy and sealing of the round window membrane in sudden sensorineural hearing loss. HNO 2013; 61:314–320.

    Article  Google Scholar 

  22. 22

    Salt AN, King EB, Hartsock JJ, Gill RM, O’leary SJ. Marker entry into vestibular perilymph via the stapes following applications to the round window niche of guinea pigs. Hear Res 2012; 283:14–23.

    Article  Google Scholar 

  23. 23

    Gouveris H, Selivanova O, Mann W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol 2005; 262:131–134.

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Khaled M. Hassan.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abdel Baki, F.A., Omran, A.A., Asal, S.I. et al. The effect of direct application of dexamethasone on the round window membrane in patients with sudden sensorineural hearing loss. Egypt J Otolaryngol 33, 631–636 (2017).

Download citation


  • dexamethasone
  • round window
  • sudden hearing loss